Arnold R M
University of Pittsburgh School of Medicine, PA 15260.
HEC Forum. 1994 Jul;6(4):257-9. doi: 10.1007/BF01452475.
In summary, it is, I believe, fairly uncontroversial that a patient always should be notified before a bioethics committee reviews the case. Respect for a patient"s confidentiality and autonomy also require that patients be asked prior to being interviewed or identifying the patient's name in a committee meeting. Permission is not required for an anonymous discussion of the case with a bioethics committee.
总之,我认为在生物伦理委员会审查病例之前,始终应该通知患者,这一点争议不大。尊重患者的保密性和自主性还要求在委员会会议上对患者进行访谈或提及患者姓名之前先征求患者意见。与生物伦理委员会进行匿名病例讨论无需获得许可。